Quality control (QC) ranges for disk diffusion susceptibility testing of aquatic bacterial isolates were proposed as a result of a multilaboratory study conducted according to procedures established by the National Committee for Clinical Laboratory Standards (NCCLS). Ranges were proposed for Escherichia coli ATCC 25922 and Aeromonas salmonicida subsp. salmonicida ATCC 33658 at 22 and 28°C for nine different antimicrobial agents (ampicillin, enrofloxacin, erythromycin, florfenicol, gentamicin, oxolinic acid, oxytetracycline, ormetoprim-sulfadimethoxine, and trimethoprim-sulfamethoxazole). All tests were conducted on standard Mueller-Hinton agar. With >95% of all data points fitting within the proposed QC ranges, the results from this study comply with NCCLS guidelines and have been accepted by the NCCLS Subcommittee for Veterinary Antimicrobial Susceptibility Testing. These QC guidelines will permit greater accuracy in interpreting results and, for the first time, the ability to reliably compare susceptibility test data between aquatic animal disease diagnostic laboratories.
In 1998, the National Committee for Clinical Laboratory Standards (NCCLS) formed the Subcommittee on Veterinary Antimicrobial Susceptibility Testing-Aquaculture Working Group (VAST-AWG) to produce a guidance document for standardizing methods of antimicrobial susceptibility testing (AST) of bacteria isolated from aquatic animal species. The working group has since relied heavily on the initial work of Barker and Kehoe (2) , the efforts of those who organized the Workshop on MIC Methodologies in Aquaculture (Weymouth, United Kingdom, 1998), and Alderman and Smith (1) , who published the draft protocols developed at the workshop. Alderman and Smith outlined the problems commonly encountered when comparing data created by aquatic animal disease diagnostic laboratories using different methods. The data generated from these different methods differ greatly from laboratory to laboratory, making it difficult to correlate susceptibility results between labs. The methods published by Alderman and Smith were termed "tentative" by the authors due to a number of "unresolved issues" (1) .
Building on the previous efforts, members of the present VAST-AWG have targeted some of these unresolved issues, such as the development of quality control (QC) limits for potential QC strains for antimicrobial agents of interest in aquaculture. Some of these antibiotics, though not yet approved for food source aquaculture purposes, are prescribed for "extralabel" use by veterinarians treating nonfood commercial and hobby aquarium fish. Since many aquatic pathogens require lower incubation temperatures, these organisms cannot be tested accurately using the NCCLS AST methods for organisms whose optimal growth temperature is 35°C. Although dilution susceptibility tests are becoming more popular, the most commonly used method of susceptibility testing in aquatic diagnostic laboratories is still the disk diffusion method (2) . Two QC strains were chosen for this multilaboratory disk diffusion study on the basis of their susceptibility profiles and their international acceptance. Aeromonas salmonicida subsp. salmonicida (ATCC 33658 and NCIMB 1102) and Escherichia coli (ATCC 25922 and NCIMB 12210) are both susceptible to a wide range of antimicrobials, grow well at low temperatures, and have been shown to be stable in the laboratory following multiple passes on artificial media. Aeromonas salmonicida subsp. salmonicida, in particular, was chosen because it has an optimum growth temperature lower than that of E. coli and is representative of aquatic pathogens. It was proposed to the NCCLS Subcommittee on VAST that both of these organisms be used as QC organisms for disk diffusion susceptibility testing of those aquatic isolates found in group 1 (Table 1) . Since there is a ban on importation of A. salmonicida subsp. salmonicida strains in some nations, E. coli should be used instead in those nations.
QC ranges were defined at two different temperatures, 22
and 28°C, to accommodate optimum temperatures for aquatic bacteria isolated from both warm-water and cold-water species. The specific temperatures were chosen on the basis of routine use in aquatic animal disease diagnostic laboratories worldwide, recommendations of the AWG, and an effort to coordinate methodologies with international investigators. The multilaboratory trial established QC ranges for nine different antimicrobial agents: ampicillin, enrofloxacin, erythromycin, florfenicol, gentamicin, oxytetracycline, ormetoprimsulfadimethoxine, trimethoprim-sulfamethoxazole, and oxolinic acid. These drugs were chosen to represent major classes of antimicrobial agents, some of which are approved for use in the United States and/or abroad. In addition, some of these drugs have been identified in the environment (3, 4) and are of growing concern to environmental regulatory agencies. Results from this study will assist in the accurate monitoring of resistance in bacteria commonly isolated from the environment.
ratory's values were consistently lower than those generated in the other participating laboratories due to the use of a magnifying lens rather than the unaided eye to interpret the zones of inhibition. As a result, the total QC data points per organism per drug per temperature per incubation time condition were reduced from 600 to 540.
Antimicrobial compounds. All antimicrobial disks were obtained from BD Diagnostic Systems (Sparks, Md.). The nine antimicrobials tested and their corresponding disk quantities and disk lot numbers were as follows: ampicillin, 10 g (lot no. . In this study, only one lot of oxolinic acid disks was available to all laboratories, but a limited supply of another lot (1046728) was made available to one of the participating laboratories.
Test strains and growth conditions. E. coli reference strain ATCC 25922 and A. salmonicida subsp. salmonicida reference strain ATCC 33658 were used to establish QC ranges at both 22 Ϯ 2 and 28 Ϯ 2°C. The Center for Veterinary Medicine at the Food and Drug Administration conducted an internal QC study with E. coli ATCC 25922 (using enrofloxacin, ampicillin, gentamicin, trimethoprim-sulfamethoxazole, oxytetracycline, and florfenicol), Pseudomonas aeruginosa ATCC 27853 (using gentamicin), and Enterococcus faecalis ATCC 29212 (using trimethoprim-sulfamethoxazole) as reference strains at 35°C with the three lots of Mueller-Hinton (MH) agar used in this study. All QC testing data points obtained from the reference strains at 35°C fell within the established QC limits found in NCCLS document M31-A2 (13) .
Disk diffusion susceptibility testing. The study was designed in accordance with NCCLS guidelines M23-A2 (11) and M37-A2 (12). On 10 testing days, each laboratory inoculated each of the control strains onto 12 MH agar plates. The MH agar was prepared by Prepared Media Laboratory (Wilsonville, Oreg.), as , resulting in a total of 540 QC data points (1 suspension ϫ 3 lots of media ϫ 2 lots of disks ϫ 10 test days ϫ 9 laboratories) for each condition.
Proposed QC strains were each tested 20 times with each agar lot for all 10 antimicrobial agents assayed. This resulted in a total of 60 possible tests by each laboratory for each antimicrobial agent and a target of 540 test values for each organism per drug per temperature per incubation time condition. For oxolinic acid, 297 total test values were recorded (30 tests per laboratory plus an additional 27 tests performed by one laboratory which had a limited number of disks from another lot).
Testing protocol. The study was performed according to the methods described in NCCLS report M42-R (9). Using a Sensi-disk self-tamping 12-place dispenser (BBL), nine antimicrobial disks were applied to each 15-by 150-mm MH agar plate. Plates were stacked no more than four high and placed in ambient air incubators at 22 or 28°C.
Definition of zones of inhibition. Each area that was detected with the unaided eye as showing no obvious, visible growth was recorded as a zone of inhibition. Faint growth or tiny colonies that were detected only with difficulty at the edge of a zone of inhibited growth were not considered. When the potentiated sulfonamides were tested, antagonists in the medium allowed some growth (6); therefore, slight growth was disregarded and the margin of heavy growth (Ͼ80% of a lawn) was used to determine the zone diameter.
RESULTS AND DISCUSSION
QC ranges were developed at 22°C (24 to 28 h and 44 to 48 h) and 28°C (24 to 28 h) for E. coli ATCC 25922 and A. salmonicida subsp. salmonicida ATCC 33658. The organisms were tested 540 times per drug per temperature condition. In accordance with NCCLS guidelines M23-A2 (11) and M37-A2 (12), the percentage of participant zone diameters that fell within the approved QC ranges exceeded 95% for each antibacterial agent tested.
MH agar was selected as the growth medium on the basis of its ability to support the growth of many aquatic isolates as well as of the QC strains. It is also specified for aerobic disk susceptibility testing methods (10) and is ion adjusted and therefore standardized. Additionally, this medium has shown good intralaboratory reproducibility of susceptibility results of tests using the QC strains as well as various aquatic isolates. The three lots of MH agar used in this study yielded minimal lot-to-lot variation within and between the laboratories for both QC organisms tested. Similarly, very little variation was observed in the zones of inhibition measured around the two different lots of antimicrobial disks tested. Table 2, Table 3 , and Table 4 summarize the zones of inhibition and QC limits for the nine antimicrobial agents tested for E. coli. The NCCLS-approved zone diameter QC ranges for the organism per drug per temperature per incubation time condition were determined by using a modification of the median method described by Gavan et al. (5) . Where appropriate, the calculated ranges were adjusted to incorporate more or fewer of the data points as long as Ն95% were included. When tested with enrofloxacin, E. coli yielded ranges considerably wider than those presently being used in disk diffusion testing of veterinary isolates at 35°C (13) . To strengthen the testing method, all ranges for E. coli tested with enrofloxacin were deemed unacceptable. When E. coli was tested with ampicillin, distinct inner and outer margins, some resembling a halo or ring of growth forming the inner margin, were observed. Some zones had individual resistant colonies inside the inner zone of inhibition. The ranges, however, were narrow and consistent among most of the laboratories, thus permitting ranges to be established for ampicillin.
Aeromonas salmonicida subsp. salmonicida produced zones of inhibition with NCCLS-approved ranges of Յ16 mm (Table  5, Table 6, and Table 7 ), which were considered acceptable QC ranges under the test conditions for all antimicrobial agents tested. When tested against the potentiated sulfonamides, A. salmonicida subsp. salmonicida yielded a very distinct inner and outer margin of growth. The antagonists in the medium allowed some slight growth inside the outer margin; however, this was not observed with E. coli. Measuring zones around these disks with A. salmonicida subsp. salmonicida as a QC organism may result in some laboratory-to-laboratory variation in the interpretation of the margin, so E. coli may be a more suitable QC organism when testing the potentiated sulfonamides. When tested with all drugs except gentamicin and enrofloxacin, larger zones of inhibition were observed at both 22 and 28°C with A. salmonicida subsp. salmonicida than with E. coli. Despite being active against primarily gram-positive and rapidly dividing bacteria, erythromycin was shown to be active against both of the E. coli and A. salmonicida subsp. salmonicida strains under in vitro conditions at the temperatures used in this study.
Results at the lower temperatures used here showed a clear decrease in the precision of the disk diffusion test, with wider ranges resulting for some of the antimicrobials tested compared to those ranges presently used at 35°C (14) . The effect of temperature on the intralaboratory and approved QC ranges of most of the test articles was apparent, with narrower ranges resulting when testing at 28 versus 22°C after 24 h. This range narrowing indicates that at 28°C, margins were more defined than at 22°C, probably due to an increased growth rate or to a temperature-dependent decrease in the drug diffusion rate at the lower temperature. Wider ranges were observed in most cases, especially with A. salmonicida subsp. salmonicida, at 22°C after 48 h versus those measured after 24 h at 22 and 28°C. This suggests that the precision of the method decreased slightly over time.
It is recognized that some of these approved ranges may be wider than those used for the same drugs at higher temperatures, but the investigators believe this is a direct effect of the decreased incubation temperature. The growth kinetics of these two organisms at the temperatures used for testing was not determined but may be a subject of interest in the future.
The methods used and ranges proposed were presented to the NCCLS Subcommittee on VAST. All methods and ranges have been accepted for inclusion in NCCLS report M42-R (9). This is the first large-scale study to establish QC ranges for AST of aquatic isolates at temperatures lower than the standard 35°C. It is envisioned that these ranges can be a nidus for future studies to establish ranges for more drugs using this core method and to develop additional standardized testing methods for fastidious aquatic pathogens (Table 1) . 
